Cisplatin Ototoxicity: Examination of the Impact of Dosing, Infusion Times, and Schedules In Pediatric Cancer Patients.

Camet, Miranda L; Spence, Anne; Hayashi, Susan S; Wu, Ningying; Henry, Jennifer; Sauerburger, Kara; Hayashi, Robert J

Camet, Miranda L; Spence, Anne; Hayashi, Susan S; Wu, Ningying; Henry, Jennifer; Sauerburger, Kara; Hayashi, Robert J.

Afiliação

Camet ML; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Spence A; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Hayashi SS; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Wu N; Biostatistics Shared Resource, Division of Public Health Sciences, Department of Surgery, The Alvin J. Siteman Comprehensive Cancer Center, Washington University School of Medicine, St. Louis, MO, United States.
Henry J; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Sauerburger K; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Hayashi RJ; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO, United States.

Front Oncol ; 11: 673080, 2021.

Article em En | MEDLINE | ID: mdl-34262862

Palavras-chave

cancer; cisplatin; dosing; ototoxicity; pediatric

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google